We use cookies to improve your experience on this website.

Cell Therapy

Whether you are looking to commercialise the next autologous or allogeneic cell therapy, CAR-T, or stem, our experienced Process Architects and Engineers will create a best in class design, fit for ‘your process’ development and manufacturing facility enabling you to rapidly bring your cell therapy product to the patients that urgently need these life-changing therapies. Contact us to discuss how we can support your next cell therapy project.


 

Back to top
DPS Group addresses the COVID-19 pandemic:
A message from Frank Keogh, CEO

Find out more Contact Us